The main target of acromegaly treatment is reaching biochemical cure, defined by normalized IGF-1 values and a random GH < 1 ng/dl, as there is clear evidence that biochemically uncontrolled acromegaly is associated with increased morbidity and mortality. The gene discussed is IGF1; the disease is acromegaly.